Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

May 31, 2013

Study Completion Date

October 31, 2017

Conditions
Aortic Dissection
Interventions
DEVICE

Valiant Thoracic Stent Graft with the Captivia Delivery System

All subjects will be implanted with this device

Trial Locations (17)

10065

New York Presbyterian Weill Cornell, New York

19104

University of Pennsylvania, Philadelphia

20010

Washington Hospital D.C., Washington D.C.

23298

Virginia Commonwealth University MCV Richmond, Richmond

27710

Duke University Medical Center, Durham

28204

Novant Health Heart and Vascular Institute, Charlotte

32610

University of Florida, Gainesville

37232

Vanderbilt Medical Center, Nashville

48109

University of Michigan, Ann Arbor

60601

Northwestern Memorial, Chicago

75230

Heart Hospital Medical Center, Dallas

77030

Baylor, Houston

Memorial Hermann Heart and Vascular Institute, Houston

St. Luke's Episcopal Hospital, Houston

90033

USC Keck School of Medicine, Los Angeles

90048

Cedars Sinai Medical Center, Los Angeles

90502

Harbor UCLA, Torrance

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Medtronic Cardiovascular

INDUSTRY